Losartan Co Austell
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
Registration
- Applicants
- 1
- Registrations
- 3
- Schedule source
- SAHPRA documentation
Applicants and registrations
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Losartan co 50/12,5 austell EACH TABLET CONTAINS LOSARTAN POTASSIUM 50,0 mg HYDROCHLOROTHIAZIDE 12,5 mg | 50/12,5Tablet | 53015553/7.1.3/0155Approved 25 April 2023 | Registered | S3 | PIPIL |
| Losartan co 100/12,5 austell EACH TABLET CONTAINS LOSARTAN POTASSIUM 100,0 mg HYDROCHLOROTHIAZIDE 12,5 mg | 100/12,5Tablet | 53015653/7.1.3/0156Approved 25 April 2023 | Registered | S3 | PIPIL |
| Losartan co 100/25 austell EACH TABLET CONTAINS LOSARTAN POTASSIUM 100,0 mg HYDROCHLOROTHIAZIDE 25,0 mg | 100/25Tablet | 53015753/7.1.3/0157Approved 25 April 2023 | Registered | S3 | PIPIL |
Regulatory status
Where S3 sits on the scale
Needs a doctor's prescription, dispensed by a pharmacist.
Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S3, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Losartan potassium, hydrochlorothiazide
S3: Hydrochlorothiazide
Consolidated Schedules 06 July 2026, line 3721
S3: Losartan
Consolidated Schedules 06 July 2026, line 3908
S3: Potassium
- when intended for intravenous infusion or for injection;
- except when contained in oral rehydration preparations; (S0)
- except in oral preparations or mixtures containing more than 20 millimoles (1500mg) of potassium per 24 hours. (S2)
Consolidated Schedules 06 July 2026, lines 4148 to 4153
S2: Potassium
- in oral preparations or mixtures containing more than 20 millimoles (1500mg) of potassium per 24 hours;
- except when intended for intravenous infusion or for injection; (S3) and
- except when contained in oral rehydration preparations. (S0)
Consolidated Schedules 06 July 2026, lines 2563 to 2569
Pharmacological class: Other hypotensives. (class 7.1.3)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Background
SAHPRA documents
Schedule Verification
Losartan co 50/12,5 austell, Austell Pharmaceuticals (Pty) Ltd is scheduled S3 in its official SAHPRA documents, read with 90% confidence.
These documents come from SAHPRA's PI-PIL repository unless the line under a document says otherwise. Always consult with a healthcare professional for medical advice.